Medicare Enrolled

Dr. David Abramowitz, M.D.

Urogynecology and Reconstructive Pelvic Surgery (Urology) Physician · Cheektowaga, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
3085 HARLEM RD STE 200, Cheektowaga, NY 14225
7168445000
In practice since 2014 (12 years)
NPI: 1265850390 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Abramowitz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Abramowitz? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Abramowitz

Dr. David Abramowitz is an urogynecology and reconstructive pelvic surgery physician in Cheektowaga, NY, with 12 years of NPI registration. Based on federal Medicare data, Dr. Abramowitz performed 1,621 Medicare services across 1,224 unique beneficiaries.

Between the years covered by Open Payments, Dr. Abramowitz received a total of $4,117 from 21 pharmaceutical and/or device companies across 55 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urogynecology and reconstructive pelvic surgery (urology) physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Abramowitz is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice ▲ Top 43% volume in NY $4,117 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,621
Medicare services
Top 43% in NY for urogynecology and reconstructive pelvic surgery (urology) physician
1,224
Unique beneficiaries
$42
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~135 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
509 $2 $15
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
295 $86 $160
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
220 $58 $115
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
130 $7 $85
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
114 $8 $8
PSA test (prostate cancer screening) 62 $18 $41
Simple insertion of temporary bladder tube
A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder.
45 $44 $200
Initial hospital admission, low complexity
Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter.
27 $65 $189
Simple change of bladder tube 26 $66 $200
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
26 $102 $251
Endoscopic removal of foreign body, stone, or stent from urethra or bladder
A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item.
24 $115 $870
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
23 $57 $100
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
20 $101 $203
Ureteral stone crushing with stent insertion
An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open.
19 $284 $1,000
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
18 $8 $30
Ureteral stent insertion via endoscope
A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder.
15 $109 $869
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
13 $93 $400
Prostate gland biopsy
A procedure to remove small samples of tissue from the prostate gland for laboratory examination.
12 $99 $500
Ultrasound guidance for needle placement
Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure.
12 $24 $300
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
11 $134 $250
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.6% high complexity
9.5% medium
86.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$4,117
Total received (2020-2024)
Avg $823/year across 5 years
Top 44% in NY for urogynecology and reconstructive pelvic surgery (urology) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
21
Companies
55
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,897 (94.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$220 (5.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$765
2023
$570
2022
$394
2021
$2,110
2020
$277

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Endologix LLC
$226
Olympus America Inc.
$143
Innovation Technologies Inc
$140
Axonics, Inc.
$79
Boston Scientific Corporation
$53
Medtronic, Inc.
$37
UROGEN PHARMA, INC.
$28
Calyxo, Inc.
$20
Integra LifeSciences Corporation
$20
Ambu Inc.
$18
Top 3 companies account for 66.6% of 2024 payments
All-time payments by company (2020-2024) ›
COLOPLAST CORP
$1,587
Endologix LLC
$368
Boston Scientific Corporation
$360
Innovation Technologies Inc
$285
Medtronic, Inc.
$248
Coloplast Corp
$200
Olympus America Inc.
$176
Medtronic USA, Inc.
$165
Intuitive Surgical, Inc.
$136
BOSTON SCIENTIFIC CORPORATION
$120
Astellas Pharma US Inc
$100
Axonics, Inc.
$79
Laborie Medical Technologies Corp.
$70
UROVANT SCIENCES INC
$60
LSI SOLUTIONS INC
$40
UROGEN PHARMA, INC.
$28
Calyxo, Inc.
$20
Integra LifeSciences Corporation
$20
DENTSPLY IH AB
$19
Ambu Inc.
$18
Allergan, Inc.
$16
Top 3 companies account for 56.2% of all-time payments
Associated products mentioned in payments ›
AMS · AMS 700 CXR RTE KIT · Alto Abdominal Stent Graft System · Axonics · BOTOX · Bulkamid · CVAC ASPIRATION SYSTEM · Da Vinci Surgical System · ENDOCROSS Device · GEMTESA · GENERAL MALE SUI · INTERSTIM · IRRISEPT · Integra · JELMYTO · LoFric · SpaceOAR VUE System - 10mL · TI KNOT · Titan · Torus Stent Graft System · iTIND System · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an urogynecology and reconstructive pelvic surgery physician in Cheektowaga?
Compare urogynecology and reconstructive pelvic surgery physicians in the Cheektowaga area by procedure volume, costs, and industry payment transparency.
Browse urogynecology and reconstructive pelvic surgery physicians nearby

Geographic Context

Urogynecology and reconstructive pelvic surgery physicians within 10 mi
4
Per 100K population
0.4
County median income
$71,175
Nearest hospital
UPSTATE NEW YORK VA HEALTHCARE SYSTEM (WESTERN NY VA HEALTHCARE SYSTEM)
3.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Abramowitz is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Abramowitz experienced with automated urinalysis?
Based on Medicare claims data, Dr. Abramowitz performed 509 automated urinalysis services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Abramowitz receive payments from pharmaceutical companies?
Yes. Dr. Abramowitz received a total of $4,117 from 21 companies across 55 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Abramowitz's costs compare to other urogynecology and reconstructive pelvic surgery physicians in Cheektowaga?
Dr. Abramowitz's average Medicare payment per service is $42. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Abramowitz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →